37. Ververeli, K., Chipps, B.E. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent acute asthma. Ann Allergy Asthma Immunol. 2004;92:512-522. View

36. Dolan, C.M., Fraher, K.E., Bleeker, E.R., Borish, L., Chipps, B.E., Hayden, M.L., et al. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with
severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92:32-39. View

35. Chipps, B.E., Schnepp, C.M., Briscoe M. Budesonide Inhalation Suspension Reduces the Need for Emergency Intervention in Pediatric Asthma: A Named-Patient Case Series. J Asthma. 2003; 40:895-900. View

34. Oppenheimer, J.J., Chipps, B.E., Corbridge T.C., Fanta, C.H. Acute asthma: The basics of assessment and treatment. J Respir Dis. 2001; 23:126-141.

33. Abrahams, N.A., Colby, T.V., Chipps, B.E., Juris, A.L., Leslie, K.O. Pulmonary hemangiomas of infancy and childhood: report of two cases and review of the literature. Pediatr Dev Pathol. 2002 May-June; 5 (3): 283-292.

32. Chipps, B.E., Chipps, D.R.: A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma. Clin Pediatrics. 2001; 40:185-189. View

31. Aquino, S.L., Schechter, M.S., Chiles C., Ablin, D.S., Chipps, B.E., Webb, W.R. High-Resolution Inspiratory and Expiratory CT in Older Children and Adults with Bronchopulmonary Dysplasia. Amer J Radiol:173:963-967, 1999.

30. Chipps, B.E., Moynihan, R., Schieble, T., Stene, R., Feaster, W., et al. Infants Undergoing Pyloromyotomy Are Not at Risk for Postoperative Apnea. Pediatr Pulmonol. 27:278-281, 1999.

***Updated 1/13/2021***


COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.


Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

Within the health care community as a whole, there has been an overall increase in the number of patients not seeking necessary medical treatment due to concerns about COVID-19.

If you have a medical problem, please contact your health care provider. It’s important not to delay seeking treatment when you need it.

We are currently open for in-office visits and will continue to offer telemedicine visits moving forward. We understand you might have concerns about coming in to see your health care provider. We want you to know about the steps we are taking to ensure your safety and help prevent the spread of infection:

o Mandatory Masking – All patients and visitors must be masked while in any of our care sites. Please wear a mask or face covering when you enter our facility.

o Limiting Individuals at Appointments – We will limit who is present at a patient visit. Only the patient will be allowed into the facility. If the patient is a minor, only one parent/guardian will be allowed to accompany the patient.

o Temperature Checks – All patients (and parent/guardian if patient is a minor) will have their temperatures checked at the door. Anyone with a temperature of 100 degrees or higher will be asked to reschedule their appointment or conduct the appointment via telemedicine.

o Employee Screening – We’ve instituted mandatory employee temperature screenings before each shift.

New Injection Hours – Effective 7/6/2020

Folsom Office
Monday 8:00-11:45 / 1-4:45
Tuesday Closed
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-4:45
Friday 8:00-11:45 / 1-4:45

Roseville Office
Monday 9:00-11:45 / 1-4:45
Tuesday 8:00-11:45 / 1-4:45
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-5:45
Friday 8:00-11:45 / 1-4:45

Monday 9:00-4:45
Tuesday 8:00-5:45
Wednesday 8:00-4:45
Thursday 9:00-4:45
Friday 8:00-4:45